Heterozygous Disease-Causing Alkaline Phosphatase (ALPL) Variants Identified Through Expanded Carrier Screening

Maternal-fetal medicine and geneticist, Karin Blakemore, M.D., and prenatal genetic counselor, Chrissy Hertenstein, discuss recent research around heterozygous disease-causing alkaline phosphatase (ALPL) variants.

Research publication: DOI: 10.1002/mgg3.2056

Share Fast Facts

Maternal-fetal medicine specialist and geneticist Dr. Karin Blakemore and prenatal genetic counselor Chrissy Hertenstein discuss recent research about heterozygous disease-causing alkaline phosphatase variants. Click to Tweet

Created by

Johns Hopkins Medicine

Related Presenters

Karin Blakemore

Karin Blakemore

Director, Prenatal Genetics, Prenatal Diagnostic Center
Professor of Gynecology and Obstetrics

EXPERTISE Dysmorphology, Fetal Ultrasound, Gynecology and Obstetrics, Hematologic Disorders in Pregnancy, Human Genetics, Maternal and Fetal Medicine, Medical Genetics-Inherited Disorders, Obstetrics, Skeletal Dysplasias RESEARCH INTERESTS Fetal ...

View full profile